|
| | Preview | Issue Date | Title | Author(s) |
| 1 | | Jun-2007 | Utility of urine drug screening: a clinical audit | Murnion, Bridin ; Granot, R.; Day, R.O. |
| 2 | | Dec-2019 | Unique approach to continuing medical education in clinical pharmacology across Australia and New Zealand | Murnion, Bridin ; Athavale, A. |
| 3 | | Nov-2018 | Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence | Murnion, Bridin ; Nielsen, S.; Lintzeris, N.; Degenhardt, L.; Bruno, R.; Haber, P.; Johnson, J.; Hardy, M.; Ling, S.; Saddler, C.; Dunlop, A.; Demirkol, A.; Silsbury, C.; Phung, N.; Houseman, J.; Larance, B. |
| 4 | | Jan-2016 | Treating codeine dependence with buprenorphine: Dose requirements and induction outcomes from a retrospective case series in New South Wales, Australia | Murnion, Bridin ; Nielsen, S.; Bruno, R.; Dunlop, A.; Degenhardt, L.; Demirkol, A.; Muhleisen, P.; Lintzeris, N. |
| 5 | | 2022 | Transferring patients from high-dose methadone to buprenorphine: A retrospective case series | Foran, Alicia; Tremonti, Chris; Balgobind, Vikash; Sakr, Hani ; Murnion, Bridin |
| 6 | | Apr-2011 | Training in addiction medicine in Australia | Murnion, Bridin ; Haber, P.S. |
| 7 | | Jan-2007 | Targeted pharmacotherapy of evoked phenomena in neuropathic pain: a review of the current evidence | Murnion, Bridin ; Granot, R.; Day, R.O.; Cohen, M.L.; Garrick, R. |
| 8 | | Jul-2017 | Supporting the Aboriginal alcohol and other drug workforce in New South Wales, Australia | Ella, Stephen ; Lee, K.S.K.; Freeburn, B.; Wilson, S.; Harrison, K.; McEwan, M.; Conigrave, K. M. |
| 9 | | 14-Jul-2023 | Substance use, socio-demographic characteristics, and self-rated health of people seeking alcohol and other drug treatment in New South Wales: baseline findings from a cohort study | Black, Emma; Bruno, Raimondo; Mammen, Kristie; Mills, Llewellyn; Siefried, Krista J; Deacon, Rachel M; Shakeshaft, Anthony; Dunlop, Adrian J; Ezard, Nadine; Montebello, Mark; Childs, Steven ; Reid, David; Holmes, Jennifer; Lintzeris, Nicholas |
| 10 | | Aug-2019 | Routine opioid outcome monitoring in community pharmacy: Pilot implementation study protocol | Murnion, Bridin ; Neilsen, S.; Kowalski, M.; Wood, P.; Larney, S.; Bruno, R.; Shanahan, M.; Lenton, S.; Dietze, P.; Green, T.; Ritter, A. |
| 11 | | Jan-2021 | Recurrent Takotsubo Cardiomyopathy Associated with Opioid Withdrawal During Buprenorphine Induction | Murnion, Bridin ; Clark, D.; Jamshidi, N. |
| 12 | | Oct-2017 | Randomised controlled trial (RCT) of daily aerobic exercise for inpatient cannabis withdrawal: A study protocol | Murnion, Bridin ; Allsop, D.J.; Rooney, K.; Arnold, J.C.; Bhardwaj, A.K.; Bruno, R.; Bartlett, D.J.; Montebello, M.; Arkell, T.; Richards, E.; Gugusheff, J. |
| 13 | | Oct-2017 | QT interval prolongation in opioid agonist treatment: analysis of continuous 12-lead electrocardiogram recordings | Gill, Anthony J ; Isbister, G.K.; Brown, A.L.; Scott, A.J.; Calver, L.; Dunlop, A.J. |
| 14 | | Jan-2010 | Prescription and administration of opioids to hospital in-patients, and barriers to effective use | Murnion, Bridin ; Gnjidic, D.; Hilmer, S.N. |
| 15 | | Jul-2015 | Pregabalin to treat ciguatera fish poisoning | Murnion, Bridin ; Brett, J. |
| 16 | | Feb-2018 | Perceived stigma and social support in treatment for pharmaceutical opioid dependence | Murnion, Bridin ; Cooper, S.; Campbell, G.; Larance, B.; Nielsen, S. |
| 17 | | Jul-2021 | Patient characteristics predicting attendance for elective in-patient treatment of substance use disorder | Murnion, Bridin ; Dhaliwal, Anupreet ; Alsop, Julian |
| 18 | | Aug-2017 | Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis | Murnion, Bridin ; Nielsen, S.; Sabioni, P.; Trigo, J.M.; Ware, M.A.; Betz-Stablein, B.D.; Lintzeris, N.; Khor, K.E.; Farrell, M.; Smith, A.; Le Foll, B. |
| 19 | | Jun-2018 | Neuropathic pain: current definition and review of drug treatment | Murnion, Bridin |
| 20 | | Dec-2015 | Medicinal cannabis | Murnion, Bridin |
| 21 | | Mar-2012 | Management of opioid substitution therapy during medical intervention | Murnion, Bridin |
| 22 | | Oct-2009 | Management of injecting drug users admitted to hospital | Murnion, Bridin ; Haber, P.S.; Demirkol, A.; Lange, K. |
| 23 | | Oct-2015 | Management of benzodiazepine misuse and dependence | Murnion, Bridin ; Brett, J. |
| 24 | | Mar-2018 | A man using codeine long term for foot pain: alternative pain management and opioid cessation | Murnion, Bridin |
| 25 | | Jun-2019 | Inpatient management of gamma-hydroxybutyrate withdrawal | Murnion, Bridin ; Cappetta, M. |
| 26 | | Dec-2021 | Implementation of a Multi-Modal Training Program for the Management of Comorbid Mental Disorders in Drug and Alcohol Settings: Pathways to Comorbidity Care (PCC) | Childs, Steven ; Louie, E.; Morley, K.C.; Giannopoulos, V.; Uribe, G.; Wood, K.; Marel, C.; Mills, K.L.; Teesson, M.; Edwards, M.; Rogers, D.; Dunlop, A.; Baillie, A.; Haber, P.S. |
| 27 | | 8-Jul-2023 | Identifying thresholds for clinically meaningful change among clients of drug and alcohol services using the Australian Treatment Outcomes Profile | Deacon, Rachel M; Mills, Llewellyn; Bruno, Raimondo; Mammen, Kristie; Dunlop, Adrian; Childs, Steven ; Shakeshaft, Anthony; Holmes, Jennifer; Lintzeris, Nicholas |
| 28 | | Jun-2011 | Hepatotoxicity of therapeutic short-course paracetamol in hospital inpatients: impact of ageing and frailty | Murnion, Bridin ; Mitchell, S.J.; Hilmer, S.N.; Matthews, S. |
| 29 | | 16-Dec-2022 | Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019 | Black, Emma; Mammen, Kristie; Deacon, Rachel M; Ezard, Nadine; Mills, Llewellyn; Dunlop, Adrian J; Montebello, Mark; Reid, David; Childs, Steven ; Bruno, Raimondo; Shakeshaft, Anthony; Siefried, Krista J; Farrell, Michael; Holmes, Jennifer; Lintzeris, Nicholas |
| 30 | | 5-Oct-2022 | Geographical variation in implementation of the Pathways to Comorbidity Care program in Australian drug and alcohol services | Louie, Eva; Giannopoulos, Vicki; Uribe, Gabriela; Wood, Katie; Teesson, Maree; Childs, Steven ; Baillie, Andrew; Haber, Paul S; Morley, Kirsten C |
| 31 | | Dec-2003 | General practitioners’ diagnostic skills and referral practices in managing patients with drug and alcohol-related health problems: Implications for medical training and education programmes | Murnion, Bridin ; Fucito, L.; Gomes, B.; Haber, P. |
| 32 | | 1993 | Excitation and inhibition of rat medial vestibular nucleus neurones by 5-hydroxytryptamine | Murnion, Bridin ; Johnston, A.R.; McQueen, D.S.; Dutia, M.B. |
| 33 | | Oct-2009 | Examination of opioid prescribing in Australia from 1992 to 2007 | Murnion, Bridin ; Leong, M.; Haber, P.S. |
| 34 | | Mar-2022 | The Effectiveness of Exercise as an Adjunct Intervention to Improve Quality of Life and Mood in Substance Use Disorder: A Systematic Review | Murnion, Bridin ; Dowla, R.; Sinmaz, H.; Mavros, Y.; Cayanan, E.; Rooney, K. |
| 35 | | Oct-2020 | The effect of daily aerobic cycling exercise on sleep quality during inpatient cannabis withdrawal: A randomised controlled trial | Murnion, Bridin ; McCartney, D.; Isik, A.D.; Rooney, K.; Arnold, J.C.; Bartlett, D.J.; Richards, E.; Arkell, T.; Lintzeris, N.; McGregor, I.S. |
| 36 | | Apr-2021 | Do gabapentin or pregabalin directly modulate the µ receptor? | Murnion, Bridin ; Manandhar, P.; Grimsey, N.L.; Connor, M.; Santiago, M. |
| 37 | | Sep-2013 | Correlates of pain in an in-treatment sample of opioid-dependent people | Murnion, Bridin ; Nielsen, S.; Larance, B.; Lintzeris, N.; Black, E.; Bruno, R.; Dunlop, A.; Degenhardt, L. |
| 38 | | Apr-2015 | Compliance with paracetamol prescribing policies at a Sydney Hospital | Murnion, Bridin ; Mitchell, S.J.; Matthews, S.T.; Hilmer, S.N. |
| 39 | | May-2015 | Comparing treatment-seeking codeine users and strong opioid users: Findings from a novel case series | Murnion, Bridin ; Nielsen, S.; Dunlop, A.; Degenhardt, L.; Demirkol, A.; Muhleisen, P.; Lintzeris, N. |
| 40 | | Aug-2010 | Combination analgesics in adults | Murnion, Bridin |
| 41 | | Oct-2018 | Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies | Murnion, Bridin ; Stockings, E.; Campbell, G.; Hall, W.D.; Nielsen, S.; Zagic, D.; Rahman, R.; Farrell, M.; Weier, M.; Degenhardt, L. |
| 42 | | Jan-2019 | Cannabinoids for the treatment of spasticity | Murnion, Bridin ; Nielsen, S.; Campbell, G.; Young, H.; Hall, W. |
| 43 | | 2021 | Buprenorphine not detected on urine drug screening in supervised treatment | Murnion, Bridin ; Jamshidi, N.; Athavale, A. |
| 44 | | Dec-2009 | The assessment of frailty in older people in acute care | Murnion, Bridin ; Hilmer, S.N.; Perera, V.; Mitchell, S.; Dent, J.; Bajorek, B.; Matthews, S.; Rolfson, D.B. |
| 45 | | Nov-2008 | Age and opioid analgesia in an acute hospital population | Murnion, Bridin ; Gnjidic, D.; Hilmer, S.N. |
| 46 | | Aug-2019 | Acute Experimental Pain Responses in Methadone- and Buprenorphine/Naloxone-Maintained Patients Administered Additional Opioid or Gabapentin: A Double-Blind Crossover Pilot Study | Murnion, Bridin ; Rivas, C.; Demirkol, A.; Hayes, V.; Lintzeris, N.; Nielsen, S. |
